Khan Sir’s Hospital and the ₹35,000 Crore Question: Can CSR Build India’s Healthcare Backbone?
- Nilofer Rohini D'Souza

- Feb 28
- 4 min read
As CSR spending scales, a low-cost hospital in Patna is raising a larger question: can corporate philanthropy move from funding programs to building healthcare capacity?
For over a decade, India’s corporate social responsibility (CSR) model followed a predictable logic.
Spend 2% of profits. Fund visible projects. Report impact.
It worked, on paper.
But in the crowded neighbourhoods of Patna, a different model has begun to attract attention. An educator better known for online lectures has been associated with a low-cost healthcare initiative in Patna, aimed at making treatments more affordable for local communities, according to publicly reported information. Detailed pricing and scale data remain limited in the public domain, but the model has drawn attention for its focus on affordability.
The story is not just about affordability.
It is about a deeper structural question:
If billions are being spent every year, why does access to affordable healthcare remain uneven?
WHY THIS STORY MATTERS
The scale of both spending and need is significant.
India’s CSR expenditure reached approximately ₹34,900 crore in FY24, according to filings under the Companies Act, 2013. Around one-fifth of this, nearly ₹7,000 crore, was directed toward healthcare.
At the same time, structural gaps persist:
Nearly 60 million Indians fall into poverty annually due to medical expenses, according to World Bank estimates
Out-of-pocket expenditure still accounts for roughly 39% of total healthcare spending
Rural India has fewer than one hospital bed per 1,000 people, significantly below urban levels, as per NITI Aayog data
The capital exists.
The capacity gap remains.
THE SHIFT
CSR in India is shifting from spending money to building systems.
For years, companies relied on dispersed initiatives, health camps, awareness drives, or NGO partnerships.
The model was compliant, visible, and relatively low-risk.
But healthcare does not scale through events.
It scales through infrastructure, beds, diagnostics, staff, and continuity of care.
That is where the existing model begins to strain.
WHAT BROKE
CSR was never designed to solve systemic problems.
The mandate, introduced under the Companies Act, 2013, was intended as a behavioural nudge. Eligible companies were required to allocate 2% of profits to social causes.
It succeeded in increasing participation.
But it also created an execution pattern:
Fragmented spending across small projects
Short-term cycles aligned with annual reporting
Visibility-driven initiatives prioritising outreach over outcomes
The result is a structural mismatch.
Healthcare requires long-term capital and operational continuity. CSR operates on annual budgets and dispersed allocation.
You cannot address a shortage of hospital beds through temporary interventions.
THE RESPONSE
This is where emerging models are drawing attention.
The Patna-based initiative associated with Khan Sir reflects a different approach, one that focuses on affordability and operational efficiency, attempting to deliver essential healthcare services at lower costs.
While detailed public data on pricing and scale varies, the broader principle is clear:
Reduce non-essential costs while maintaining core medical services.
This is not entirely new, but it is underrepresented in CSR-led initiatives.
Some corporates have experimented with more structured healthcare delivery:
Sanofi India has supported large-scale vaccination and awareness programmes through CSR partnerships
Hindustan Zinc operates rural healthcare centres serving local communities
Oil India has deployed mobile medical units in underserved regions
These efforts demonstrate reach.
But they remain largely programmatic rather than infrastructure-driven.
BREAKPOINT
The current CSR model breaks at one critical point:
It funds healthcare access, but not healthcare capacity.
Without sustained investment in infrastructure, hospitals, diagnostics, and trained personnel, the system continues to rely heavily on public health facilities that are already under pressure.
This is the gap.
REALITY CHECK
Shifting CSR toward infrastructure is not straightforward.
Several constraints remain:
Sustainability: Hospitals require continuous funding, not annual CSR allocations
Return timelines: Healthcare investments are long-term, often beyond corporate planning cycles
Regulation: Land acquisition, licensing, and compliance vary across states
Execution complexity: Healthcare delivery involves clinical, operational, and governance risks
There is also a structural limitation.
CSR projects are often evaluated on immediate outputs, number of beneficiaries, camps conducted, or funds deployed, not on long-term system outcomes.
This creates an incentive mismatch.
STRATEGIC IMPLICATION
The next phase of CSR may require a shift in how impact is defined.
From:
Activities → Assets
Spend → Capacity
Visibility → Outcomes
Some policy discussions have already explored targeted allocations for priority sectors, including healthcare infrastructure.
The larger strategic question for India Inc. is not about compliance.
It is about capability.
If CSR capital can be pooled, structured, and aligned with long-term models, it could potentially support scalable healthcare infrastructure, particularly in underserved regions.
THE BIGGER PICTURE
India’s growth story is increasingly defined by access.
Access to credit.Access to digital infrastructure.And increasingly, access to healthcare.
CSR was designed as a bridge between profit and purpose.
The next phase may determine whether that bridge funds intent, or builds capacity.
Because if billions continue to be spent without creating infrastructure, the gap will persist.
And if even a small portion of that capital shifts toward long-term capacity building, the impact could extend far beyond individual projects.
The question is no longer how much is being spent.
It is what is being built.

DISCLAIMER
This article is part of Business Story Network’s editorial coverage of business, strategy, and emerging sectors in India. Information is based on publicly available data, industry reports, and sectoral observations. It is intended for informational purposes and does not constitute financial or investment advice.




Comments